Westpac Banking Corp’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.37M | Sell |
38,870
-2,811
| -7% | -$269K | 0.23% | 105 |
|
|
2025
Q4 | $4M | Buy |
41,681
+4,174
| +11% | +$405K | 0.25% | 97 |
|
|
2025
Q3 | $3.57M | Buy |
37,507
+34,673
| +1,223% | +$3.19M | 0.22% | 107 |
|
|
2025
Q2 | $247K | Sell |
2,834
-1,573
| -36% | -$133K | 0.02% | 324 |
|
|
2025
Q1 | $396K | Sell |
4,407
-97
| -2% | -$8.68K | 0.03% | 273 |
|
|
2024
Q4 | $360K | Sell |
4,504
-111
| -2% | -$9.61K | 0.02% | 307 |
|
|
2024
Q3 | $415K | Buy |
4,615
+1,613
| +54% | +$136K | 0.03% | 293 |
|
|
2024
Q2 | $236K | Buy |
+3,002
| New | +$246K | 0.02% | 315 |
|
|
2023
Q2 | – | Sell |
-112,323
| Closed | -$9.06M | – | 670 |
|
|
2023
Q1 | $9.06M | Sell |
112,323
-2,500
| -2% | -$204K | 0.12% | 211 |
|
|
2022
Q4 | $8.92M | Buy |
114,823
+463
| +0.4% | +$37.5K | 0.13% | 199 |
|
|
2022
Q3 | $9.23M | Sell |
114,360
-1,234
| -1% | -$111K | 0.14% | 196 |
|
|
2022
Q2 | $10.4M | Sell |
115,594
-3,614
| -3% | -$366K | 0.14% | 204 |
|
|
2022
Q1 | $13.2M | Hold |
119,208
| – | – | 0.15% | 174 |
|
|
2021
Q4 | $12.3M | Sell |
119,208
-35,998
| -23% | -$4.17M | 0.13% | 199 |
|
|
2021
Q3 | $19.5M | Sell |
155,206
-6,711
| -4% | -$869K | 0.21% | 117 |
|
|
2021
Q2 | $20.1M | Buy |
+161,917
| New | +$20.3M | 0.2% | 127 |
|
|
2021
Q1 | – | Sell |
-151,896
| Closed | -$17.8M | – | 820 |
|
|
2020
Q4 | $17.8M | Buy |
151,896
+13,501
| +10% | +$1.49M | 0.2% | 125 |
|
|
2020
Q3 | $14.4M | Sell |
138,395
-1,575
| -1% | -$158K | 0.19% | 132 |
|
|
2020
Q2 | $12.8M | Sell |
139,970
-26,811
| -16% | -$2.57M | 0.19% | 133 |
|
|
2020
Q1 | $15M | Buy |
166,781
+20,363
| +14% | +$2.17M | 0.26% | 101 |
|
|
2019
Q4 | $16.6M | Sell |
146,418
-201
| -0.1% | -$22.1K | 0.21% | 126 |
|
|
2019
Q3 | $15.9M | Buy |
+146,619
| New | +$15.3M | 0.22% | 121 |
|
|
2019
Q1 | – | Sell |
-452,672
| Closed | -$41.2M | – | 779 |
|
|
2018
Q4 | $41.2M | Buy |
+452,672
| New | +$42.3M | 0.7% | 19 |
|
|
2017
Q4 | – | Sell |
-412,410
| Closed | -$32.1M | – | 749 |
|
|
2017
Q3 | $32.1M | Buy |
412,410
+8,656
| +2% | +$719K | 0.71% | 19 |
|
|
2017
Q2 | $35.8M | Sell |
403,754
-80,124
| -17% | -$6.76M | 0.79% | 18 |
|
|
2017
Q1 | $39M | Buy |
483,878
+473,401
| +4,518% | +$37M | 0.31% | 76 |
|
|
2016
Q4 | $1.03M | Buy |
10,477
+239
| +2% | +$18.8K | 0.01% | 572 |
|
|
2016
Q3 | $885K | Sell |
10,238
-341,885
| -97% | -$29.8M | 0.01% | 580 |
|
|
2016
Q2 | $30.3M | Buy |
352,123
+25,423
| +8% | +$2.06M | 0.33% | 73 |
|
|
2016
Q1 | $24.5M | Buy |
326,700
+315,703
| +2,871% | +$23.8M | 0.27% | 85 |
|
|
2015
Q4 | $846K | Buy |
10,997
+361
| +3% | +$27.2K | 0.01% | 600 |
|
|
2015
Q3 | $712K | Buy |
10,636
+2,089
| +24% | +$154K | 0.01% | 580 |
|
|
2015
Q2 | $633K | Sell |
8,547
-60,817
| -88% | -$4.65M | 0.01% | 529 |
|
|
2015
Q1 | $7.08M | Sell |
69,364
-328,796
| -83% | -$24.9M | 0.06% | 294 |
|
|
2014
Q4 | $28.7M | Sell |
398,160
-110,270
| -22% | -$7.66M | 0.27% | 76 |
|
|
2014
Q3 | $31.5M | Sell |
508,430
-390,961
| -43% | -$24.9M | 0.31% | 62 |
|
|
2014
Q2 | $57.3M | Sell |
899,391
-47,495
| -5% | -$2.89M | 0.55% | 34 |
|
|
2014
Q1 | $58.3M | Buy |
946,886
+62,717
| +7% | +$3.65M | 0.62% | 34 |
|
|
2013
Q4 | $50.7M | Sell |
884,169
-109,231
| -11% | -$6.19M | 0.58% | 34 |
|
|
2013
Q3 | $52.9M | Buy |
993,400
+188,991
| +23% | +$10.2M | 0.66% | 31 |
|
|
2013
Q2 | $39.2M | Buy |
+804,409
| New | +$39.8M | 0.6% | 38 |
|
Other funds holding MDT
VCM
VPM
Westpac Banking Corp's MDT Position: Q1 2026 in Review
Westpac Banking Corp reduced its Medtronic (MDT) stake by 6.7% in Q1 2026, selling an estimated $269K and leaving 38,870 shares worth $3.37M. The position accounts for 0.23% of the portfolio, ranked #105.
Westpac Banking Corp first reported a position in MDT in Q2 2013 and has held it in 41 quarters since. The position peaked at $58.3M in Q1 2014. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Westpac Banking Corp held 38,870 shares of Medtronic worth $3.37M as of Q1 2026.
- Westpac Banking Corp sold 2,811 Medtronic shares in Q1 2026, an estimated $269K.
- Medtronic made up 0.23% of Westpac Banking Corp's portfolio in Q1 2026, its #105 holding.
- Westpac Banking Corp first reported a position in Medtronic in Q2 2013 and has held it in 41 quarters since.
- Westpac Banking Corp's Medtronic position peaked at $58.3M in Q1 2014.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Westpac Banking Corp's 13F filing for Q1 2026, filed 12 May 2026.